Pamako

Pamako is a Greek healthcare and nutraceutical company specializing in the production of high-phenolic extra virgin olive oil (EVOO) for medicinal applications. The company's products are characterized by exceptionally high concentrations of oleocanthal and oleacein, which have been the subject of clinical research for their anti-inflammatory, antioxidant, and anti-cancer properties. Pamako's oil is currently being evaluated in clinical trials for its potential to slow the progression of Chronic Lymphocytic Leukemia (CLL) and improve cognitive function in patients with mild cognitive impairment. The company operates at the intersection of premium food production and biotechnology, focusing on the therapeutic benefits of Mediterranean diet components. Its research collaborations with academic institutions aim to validate the use of specific olive oil polyphenols as adjunct therapies for chronic diseases.